Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy - Concepedia

Concepedia

Publication | Open Access

Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy

DOI Full Paper Access

260

Citations

32

References

2004

Year

Winnie Yeo, Paul K.S. Chan, Wing Ming Ho, Benny Zee, Kwok Chi Lam, Kenny I. K. Lei, Anthony T.�C. Chan, Tony Mok, Jam J. Lee, Thomas Leung,

Journal of Clinical Oncology

Abstract

Prophylactic lamivudine significantly reduced the incidence of HBV reactivation and the overall morbidity of cancer patients undergoing chemotherapy.

References

	Year	Citations

Page 1